Pharma majors continue to recall products in US
Glenmark, Strides Pharma, Cipla face several mfg, packaging issues
image for illustrative purpose
New Delhi: Drug makers Glenmark, Strides Pharma and Cipla are recalling products in the US, the world's largest market for medicines, due to manufacturing issues.
As per the latest Enforcement Report issued by the US Food and Drug Administration (USFDA), New Jersey-based Glenmark Pharmaceuticals Inc is recalling over 72,000 units of blood pressure lowering drug due to packaging issues. The USFDA noted in its report that the company, a subsidiary of Mumbai-based drug firm, is recalling the affected lot due to blister package issues.
The lot was produced at Glenmark's Pithampur (Madhya Pradesh) based manufacturing facility. The USFDA stated that Glenmark initiated the Class II nationwide (US) recall on June 29 this year.
